AKT1 and ovarian cancer: The PI3K/AKT/mTOR signaling pathway is frequently hyperactivated in ovarian cancer, contributing to uncontrolled cell proliferation, survival, and resistance to therapy (Ghoneum et al., 2020; Rinne et al., 2021).